Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$332K Buy
13,769
+300
+2% +$7.85K 0.07% 140
2026
Q1
$378K Sell
13,469
-822
-6% -$21.9K 0.09% 119
2025
Q4
$356K Buy
14,291
+34
+0.2% +$857 0.09% 123
2025
Q3
$363K Buy
14,257
+31
+0.2% +$765 0.1% 122
2025
Q2
$345K Buy
14,226
+15
+0.1% +$350 0.1% 129
2025
Q1
$360K Sell
14,211
-838
-6% -$21.9K 0.11% 116
2024
Q4
$399K Buy
15,049
+201
+1% +$5.45K 0.13% 108
2024
Q3
$430K Sell
14,848
-28
-0.2% -$817 0.14% 100
2024
Q2
$416K Sell
14,876
-678
-4% -$18.7K 0.15% 97
2024
Q1
$432K Buy
15,554
+466
+3% +$12.9K 0.17% 95
2023
Q4
$434K Sell
15,088
-53,720
-78% -$1.62M 0.21% 92
2023
Q3
$2.28M Buy
68,808
+10,230
+17% +$362K 1.28% 23
2023
Q2
$2.15M Buy
58,578
+20,360
+53% +$792K 1.24% 17
2023
Q1
$1.56M Buy
+38,218
New +$1.65M 1% 21

Other funds holding PFE

Channel Wealth's PFE Position: Q2 2026 in Review

Channel Wealth increased its Pfizer (PFE) stake by 2.2% in Q2 2026, buying an estimated $7.85K and bringing the position to 13,769 shares worth $332K. The position accounts for 0.07% of the portfolio, ranked #140.

Channel Wealth first reported a position in PFE in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.28M in Q3 2023. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Channel Wealth held 13,769 shares of Pfizer worth $332K as of Q2 2026.
  • Channel Wealth bought 300 Pfizer shares in Q2 2026, an estimated $7.85K.
  • Pfizer made up 0.07% of Channel Wealth's portfolio in Q2 2026, its #140 holding.
  • Channel Wealth first reported a position in Pfizer in Q1 2023 and has held it in 14 quarters since.
  • Channel Wealth's Pfizer position peaked at $2.28M in Q3 2023.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Channel Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.